We have previously reported that STING restrains MDSC differentiation by decreasing IL1β and IL-6 production from NPC or CD33+ cells through suppressing the SOCS1/STAT3 signaling pathway22. The gene discussed is CD33; the disease is nasopharyngeal carcinoma.